Central Manchester University Hospitals NHS Foundation Trust (CMFT) adopts ZedScan
December 9, 2015
Central Manchester University Hospitals NHS Foundation Trust (CMFT) has introduced ZedScan™ into its cervical cancer care pathway.
The system will be utilised at the Gynaecology department at Saint Mary’s Hospital, Manchester – a centre of excellence in the field of gynaecological oncology, uro-gynaecology and reproductive medicine.
ZedScan™ can measure and detect tissue changes in women identified with an abnormal smear test.
The system offers real-time and more accurate detection of pre-cancerous cells than standard colposcopy (a procedure for examining the cervix), enabling clinicians to make better informed decisions at a patient’s first visit.
Dr Ursula Winters, Consultant Gynaecologist and lead consultant for colposcopy at Saint Mary’s, said: “The introduction of Zedscan will provide us with the ability to assess women presenting with abnormal cervical smears more quickly and accurately.
“Having access to the latest in advanced diagnostic technologies such as ZedScan means we can offer our patients efficient and rapid access to appropriate treatments when they need them.”